Wang et al. reported that methyl-CpG binding protein 2 (Mecp2) k271la inhibits epithelial regulator protein expression by altering epidermal growth factor receptor phosphorylation levels, impacting the mitogen-activated protein kinase (MAPK) signaling pathway and improving atherosclerosis 45. This evidence concerns the gene MECP2 and atherosclerosis.